Search
for

    Sort by

    Research 991–1000 of 1000+

    1. Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C. PubMed · 2007 · 4 citations
    2. Current and future pharmacotherapy for alopecia areata Expert opinion on orphan drugs · 2015 · 2 citations
    3. Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject Acta Dermato Venereologica · 2007 · 2 citations
    4. Clinical Characteristics and Factors Associated with Hair Loss Severity in Chronic Hepatitis B Patients Receiving Pegylated Interferon-Alpha: A Retrospective Cohort Study Clinical Cosmetic and Investigational Dermatology · 2026
    5. JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias International Journal of Dermatology · 2025
    6. A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report Journal of Gastroenterology and Hepatology · 1993 · 17 citations
    7. Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects Expert Opinion on Drug Safety · 2011 · 17 citations
    8. Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report Annals of Hepatology · 2014 · 3 citations
    9. LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome 2022 · 1 citations
    10. Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease Stem Cell Research & Therapy · 2020 · 118 citations